Akshay Vaishnaw
Director/Board Member presso SCHOLAR ROCK HOLDING CORPORATION
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Il Dr. Akshay K. Vaishnaw è un amministratore indipendente di Scholar Rock Holding Corp., un amministratore indipendente di Editas Medicine, Inc., un presidente-ricerca e sviluppo di Alnylam Pharmaceuticals, Inc. e un membro del The Royal College of Physicians. Fa parte del Consiglio di amministrazione di Scholar Rock Holding Corp., Scholar Rock, Inc. e Editas Medicine, Inc. Il Dr. Vaishnaw è stato precedentemente impiegato come Senior Director-Translational Medicine da Biogen Idec, Inc. È stato anche membro del consiglio di amministrazione di Visterra, Inc. Si è laureato presso l'Università di Cardiff, ha conseguito un dottorato presso la Cardiff University School of Medicine e un dottorato presso l'Università di Londra.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 04/08/2023 | 23 289 ( 0.02% ) | 3 M $ | 31/03/2024 | |
| 21/06/2023 | 9 455 ( 0.01% ) | 167 921 $ | 31/03/2024 | |
EDITAS MEDICINE, INC.
-.--% | 01/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Akshay Vaishnaw
| Società | Posizione | Inizio |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/10/2023 |
| EDITAS MEDICINE, INC. | Director/Board Member | 28/07/2016 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 21/05/2019 |
| The Royal College of Physicians | Corporate Officer/Principal | 07/07/2009 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Director/Board Member | 01/05/2019 |
Precedenti posizioni note di Akshay Vaishnaw
| Società | Posizione | Fine |
|---|---|---|
| VISTERRA INC | Director/Board Member | 01/07/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2005 |
Formazione di Akshay Vaishnaw
| University of London | Doctorate Degree |
| University of Cardiff | Undergraduate Degree |
| Cardiff University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Akshay Vaishnaw
